Pharmaceutical giant AstraZeneca has just announced that it has withdrawn its Covid vaccines globally after evidence recently emerged showing that the shots have been linked to sudden deaths.
The company announced the worldwide withdrawal of its Oxford-AstraZeneca vaccine, branded as Vaxzevria, after it was found to cause deadly blood clots.
As Slay News reported, the British-Swedish Big Pharma firm made the admission in court documents submitted in response to a class action lawsuit currently underway in the UK High Court.
The acknowledgment is a significant U-turn after over three years of pushing claims that the injections are “safe and effective.”
The move comes as deaths and severe injuries from the injection continue to soar, increasingly resulting in victims seeking substantial damages.
The shot was developed in collaboration with Oxford University in the UK and produced by the Serum Institute of India.
The vaccine is understood to have also triggered similar legal action against the firm in Italy, Germany, and other countries.
Representing a dramatic shift from its previous stance, AstraZeneca now admits that its COVID-19 vaccine can lead to Thrombosis with Thrombocytopenia Syndrome (TTS).
TTS is a condition characterized by blood clotting and low platelet levels.
According to the National Library of Medicine, TTS carries a high fatality rate.
TTS has a high risk of sudden death caused by unexpected cardiac arrest.
The admission, contained in court documents, contrasts with the company’s previous assertions denying a direct link with the syndrome.
Following the bombshell admission in court, the company withdrew its “marketing authorization” in the European Union this week.
Similar actions are expected soon in the UK and other approving countries.
Despite the timing of the move, however, the drug maker described the decision as being driven by “commercial reasons.”
The company claims the withdrawal coincides with the availability of newer vaccines designed to combat emerging variants.
AstraZeneca maintains that the decision to pull the vaccine is unrelated to the ongoing legal challenges or its potential side effects.
In a statement, the company said:
“We are incredibly proud of the role Vaxzevria played in ending the global pandemic.
“According to independent estimates, over 6.5 million lives were saved in the first year of use alone, and over three billion doses were supplied globally.
“Our efforts have been recognized by governments around the world and are widely regarded as being a critical component of ending the global pandemic.”
The European Medicines Agency has begun the process to formally withdraw the vaccine.
The withdrawal reflects an expected move away from monovalent vaccines, which target only the original COVID-19 strain.
Marco Cavaleri, head of vaccines at the agency, emphasized that this is a standard procedure for vaccines that are no longer in use.
Legal experts and victims, however, see the withdrawal as a vindication of their long-held concerns over the vaccine’s safety.
In a statement, Sarah Moore, a partner at Leigh Day, the law firm representing many of the claimants, said the move will be “welcomed” by the victims and their families.
“To those who we represent, all of whom have suffered bereavement or serious injury as a result of the AstraZeneca vaccine, this decision to withdraw marketing authorization, ending the usage of the AstraZeneca vaccine in the EU, will be welcomed,” Moore said.
“It will be seen as a decision linked with AstraZeneca’s recent admission that the vaccine can cause TTS and the fact that regulators across the world suspended or stopped usage of the vaccine following concerns regarding TTS.”
Victims and their families have reported a range of severe reactions.
Side effects range from fatal thrombosis to lasting disabilities.
The sudden deaths and injuries sparked a debate over the adequacy of vaccination safety monitoring and compensation for vaccine injuries.
Kate Scott, whose husband suffered a permanent brain injury after receiving the injection, expressed mixed feelings:
“AstraZeneca’s Covid vaccine no longer being used in the UK or Europe, and soon the rest of the world, means no one else will suffer from this awful adverse reaction,” she said.
“They say it is for commercial reasons, but maybe it’s because it can no longer be seen as being within the acceptable safety parameters, with 445 confirmed cases of VITT, 81 of these fatal in the UK alone.”
The government’s vaccine damage payment scheme has been criticized for not providing sufficient compensation, prompting calls for reform.
“This is an important regulatory step, but still our clients remain without fair compensation,” Moore added.
“We will continue to fight for the compensation our clients need and campaign for reform of the vaccine damage payment scheme.”
https://slaynews.com/news/astrazeneca-pulls-covid-vaccines-globally-evidence-links-injections-sudden-deaths/
No comments:
Post a Comment